Does ANAKINRA Cause Pulmonary fibrosis? 175 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 175 reports of Pulmonary fibrosis have been filed in association with ANAKINRA (Kineret). This represents 1.4% of all adverse event reports for ANAKINRA.
175
Reports of Pulmonary fibrosis with ANAKINRA
1.4%
of all ANAKINRA reports
8
Deaths
132
Hospitalizations
How Dangerous Is Pulmonary fibrosis From ANAKINRA?
Of the 175 reports, 8 (4.6%) resulted in death, 132 (75.4%) required hospitalization, and 13 (7.4%) were considered life-threatening.
Is Pulmonary fibrosis Listed in the Official Label?
Yes, Pulmonary fibrosis is listed as a known adverse reaction in the official FDA drug label for ANAKINRA.
What Other Side Effects Does ANAKINRA Cause?
Off label use (4,317)
Drug ineffective (3,368)
Pain (1,344)
Condition aggravated (1,339)
Rheumatoid arthritis (1,300)
Drug intolerance (946)
Joint swelling (921)
Injection site pain (879)
Product dose omission issue (864)
Arthralgia (850)
What Other Drugs Cause Pulmonary fibrosis?
METHOTREXATE (2,912)
ADALIMUMAB (2,277)
RITUXIMAB (2,192)
ETANERCEPT (1,926)
TOCILIZUMAB (1,886)
ABATACEPT (1,828)
HYDROXYCHLOROQUINE (1,740)
LEFLUNOMIDE (1,731)
PREDNISONE (1,692)
INFLIXIMAB (1,595)
Which ANAKINRA Alternatives Have Lower Pulmonary fibrosis Risk?
ANAKINRA vs ANAMORELIN
ANAKINRA vs ANASTROZOLE
ANAKINRA vs ANDEXANET ALFA
ANAKINRA vs ANDROGEL
ANAKINRA vs ANETHOLTRITHION